America's Best in Medicine Highlights Terry Guido: Biospecimen Lab Manager

Sep 29, 2026


Advancing Neuropathology Research, Biospecimen Operations, and Biotechnology Innovation for Over Two Decades


Pleasant Hill, California Sep 28, 2026 (Issuewire.com) - Terry Guido is an accomplished Biospecimen Lab Manager with more than two decades of experience in biotechnology, laboratory operations, and neuropathology research. She is currently affiliated with Roche Molecular Systems in Pleasant Hill, California, where she oversees biorepository operations and biospecimen management. Recognized for her precision, operational leadership, and scientific rigor, Terry has played a key role in advancing laboratory systems that support both clinical and preclinical research.

Throughout her career, Terry has led cross-functional laboratory initiatives and ensured compliance with critical regulatory frameworks, including OSHA, Good Laboratory Practice (GLP), ISO standards, and Quality System Regulation (QSR). She has supported successful safety, quality, and regulatory audits while also implementing advanced laboratory instrumentation and developing efficient systems for biospecimen tracking, storage, and analysis. Her technical expertise includes immunohistochemistry, fluorescence microscopy, animal model characterization, and quantitative image analysis.

Terry's career foundation was built during nearly 21 years at Elan Pharmaceuticals, where she contributed significantly to medical technology and neuropathology research. Beginning in the histology laboratory services, she advanced into leadership roles as she became deeply involved in Alzheimer's disease research. She played an instrumental role in characterizing one of the earliest transgenic mouse models of Alzheimer's-like pathology (PDAPP), helping define disease onset, progression, and neuropathological markers critical to therapeutic development.

Her expertise in image analysis supported the quantification of pathological burden, including dystrophic neurites, contributing to efficacy studies, regulatory submissions, and peer-reviewed publications. Following the transition of Elan's Alzheimer's Immunotherapy Program to Janssen Alzheimer Immunotherapy Research and Development, Terry served in dual operational roles supporting both organizations. Her responsibilities included neuropathology operations, outsourcing strategy, contract management, and budget forecasting, contributing to the advancement and eventual commercialization of Alzheimer's immunotherapy research.

In addition to her technical contributions, Terry is widely recognized for her leadership, ethical integrity, and mentorship. She has managed vendor and CRO relationships, designed laboratory spaces, overseen equipment transfers and recalibrations, and maintained sample and reagent databases. As a member of laboratory safety committees and a mentor to junior scientists, she is known for balancing scientific excellence with operational efficiency. Her achievements have been honored with multiple Elan Awards of Excellence and the Janssen Encore Award for special achievement. 

Holding a Master's Degree from the University of California, Davis, Terry Guido remains a respected leader in biotechnology, neuroscience research, and biospecimen operations. Through her continued contributions, she supports the advancement of scientific discovery and the development of the critical infrastructure that drives modern biomedical research worldwide.

Learn more about Terry Guido:

Through her America's Best in Medicine profile, https://americasbestinmedicine.com/connect/Terry-Guido

America's Best in Medicine

America's Best in Medicine is a specialist online platform dedicated to amplifying the voices of leading healthcare professionals across the United States. They bring together top healthcare providers from all specialties and cities to share expert-driven articles, research, commentary, and clinical insight. Their core purposes are to showcase excellence in healthcare, build trust between providers and the public, and ensure that expert voices are elevated and heard in shaping medicine. Through their platform, users can access a community of leaders, opportunities for providers to share expertise, and trusted guidance for patients and peers alike.

Media Contact

America's Best in Medicine


*****@americasbestinmedicine.com

1-877-346-0175

https://americasbestinmedicine.com

Source :Terry Guido

This article was originally published by IssueWire. Read the original article here.

More News
Haze: Which schools are closed on Monday? Here's the list
Haze: Which schools are closed on Monday? Here's the list

Oct 11, 2026

Parents are advised to monitor updates from Education Ministry for latest announcements....

N Sembilan crisis: No reason to delay new excos' appointments - Loke
N Sembilan crisis: No reason to delay new excos' appointments - Loke

Oct 11, 2026

DAP chief says many state administration matters require the exco's approval....

Shipbuilder told to expedite work as LCS delivery slips further
Shipbuilder told to expedite work as LCS delivery slips further

Oct 11, 2026

Khaled says this after delivery of first ship pushed to April next year....

When car's rear axle takes a detour, RTD slams the brakes
When car's rear axle takes a detour, RTD slams the brakes

Oct 11, 2026

Authorities suspend Chery Omoda 5's vehicle type approval following viral incident....

Budget 2027: Tax measures to benefit M40, boost investment - audit firm
Budget 2027: Tax measures to benefit M40, boost investment - audit firm

Oct 11, 2026

PwC Malaysia lauds expanded personal tax relief, Global Services Hub incentive enhancements, among others....

YOURSAY | Deepavali v Diwali: Not mere pedantry, but more important issues abound
YOURSAY | Deepavali v Diwali: Not mere pedantry, but more important issues abound

Oct 11, 2026

‘I’m sure there’s no malice, but these things make Tamil Malaysians feel increasingly vulnerable.’...

Sole proprietor or Sdn Bhd? How a little-known rule played out for tuition centres
Sole proprietor or Sdn Bhd? How a little-known rule played out for tuition centres

Oct 11, 2026

Experiences show that surviving under the old policy followed no single formula....

Safe vs bold reforms: Economists size up Putrajaya's Budget 2027 against Bersama's alternative
Safe vs bold reforms: Economists size up Putrajaya's Budget 2027 against Bersama's alternative

Oct 10, 2026

Analyst says party’s shadow budget advocates more fundamental reforms....

Afif hits back at Ronald over Bersatu-Harapan pact claims
Afif hits back at Ronald over Bersatu-Harapan pact claims

Oct 10, 2026

He blames Beluran MP for Bersatu’s worsening ties with PN....

Jalaluddin denies no-confidence motion against N Sembilan MB, Zahid gives assurance
Jalaluddin denies no-confidence motion against N Sembilan MB, Zahid gives assurance

Oct 10, 2026

UPDATED 8PM | State administration is running smoothly with no leadership crisis, says Umno leader....

El-Sisi reaffirms two-state solution, praises Malaysia’s support for Palestinians
El-Sisi reaffirms two-state solution, praises Malaysia’s support for Palestinians

Oct 10, 2026

Palestine issue among key matters discussed with Anwar....

Festive decorations: Use 'Deepavali', not 'Diwali' - Saravanan tells FT minister
Festive decorations: Use 'Deepavali', not 'Diwali' - Saravanan tells FT minister

Oct 10, 2026

Term better reflects linguistic, cultural background of Malaysia's Indian community, says MIC leader....

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

ABOUT US
Akhbar Harian

Akhbar Harian is your minute-to-minute update on Malaysian news keeping you in touch within the local community or in another state.

Contact us: sales[at]akhbarharian.com



SUBSCRIBE
Copyright © 2015 - 2026 Akhbar Harian. All Rights Reserved.